å»çæ©åšå ¬è¡šãããæŽå¯
ãããã¯ã©ã³ã 黿°ççåŠ ã€ãªã³ ãã£ãã«ã調æ»ããããã«å©çšãããéèŠãªæè¡ã现èèãæž¡ãã€ãªã³ã®æµããå¯èœã«ããå¿ èŠãªèèçœè³ªã ã€ãªã³ãã£ãã«ã¯ãã»ãšãã©ãã¹ãŠã®ççåŠçããã»ã¹ã«é¢äžããŠãããããéèŠãªè¬çåŠçç®æšã§ããããã®æ©èœé害ã¯å€ãã®ç æ°ãåŒãèµ·ããå¯èœæ§ããããŸãã1990幎代åŸåã2000幎代åé ã«èªåãããã¯ã©ã æè¡ãéçº ãã®æè¡ã¯ãããã¯ã©ã³ãã®äº€æãå«ã¿ãŸã ãããã å¹³é¢åºæ¿ã§å®éšã容æã«ããã èªåãããã¯ã©ã³ãã·ã¹ãã ã¯ãã€ãªã³ãã£ãã«ã®åµè¬ããã»ã¹ãç°¡åã«ããã¹ã«ãŒããããšåŒ·åãããã·ã³ãã«ããæäŸããŸããã°ããŒãã«ãªèªåãããã¯ã©ã³ãã·ã¹ãã åžå Žã¯ã U... ãã£ãšèŠã
çæ®äžèœã®å€ç§æè¢ã¯å€ç§åŠçœ®ã®éã«å€ç§å»ãããŠä»ã®ãã«ã¹ã±ã¢ã®å°éå®¶ã«ãã£ãŠèº«ã«çããŠããŸãã ãããã®å€ç§æè¢ã¯ãç¹ã«æŽåœ¢å€ç§æè¡äžã«ã埮çç©ã现èã®æ±æãææçãããã³ãšã³ããªãé¿ããããã®éå£ãšããŠæ©èœããŸãããªãŒã¹ãã©ãªã¢ãšãã¥ãŒãžãŒã©ã³ãã®æ» èæè¡ æè¢ åžå Žã¯è©äŸ¡ããããšæšå®ãããŸã AUD 59.64çŸäžå ãåãåãã 2020幎1æ19æ¥ å±ç€ºäºå® 5.6%ã®CAGR äºå ±æéäž (2020-2027)ãåãåãããããã£ãŒã« 1. ãªãŒã¹ãã©ãªã¢ãšãã¥ãŒãžãŒã©ã³ãã®ç¡èæè¡çšæè¢åžå ŽäŸ¡å€(AUD Mn)ãåœã2020幎ãªãŒã¹ãã©ãªã¢ãšãã¥ãŒãžãŒã©ã³ãã®ç¡èæè¡çšæè¢åžå Žã®æ... ãã£ãšèŠã
è ã®åãéåžå ŽèŠæš¡ãšäºæž¬ â 2025 â 20322025幎ãã2032幎ãŸã§ã«ãäžçè ã®åãéåžå ŽèŠæš¡ã¯1.2åç±³ãã«ã«å€ãããšæšå®ããã2032幎ãŸã§ã«1åç±³ãã«ã«2åç±³ãã«ã«éãããšäºæ³ãããããããã£ãŒã«è ã®åãéã¯å°¿éããŒãããã®éŠã«æ¯ããããšã«ãã£ãŠå¥³æ§ã®å§åå°¿è·¯ã®incontinence (SUI)ãæ±ãããã«èšèšãããŠããå»åŠã®æ³šå ¥ã§ãã ãããã®åãéã¯ãéåžžãããªãããã¬ã³ãªã©ã®åæã¡ãã·ã¥ææããäœãããŠããŸãããŸãã¯ãèªåŸçãŸãã¯ã¢ãšã°ã©ãçµç¹ã®ãããªçç©åŠçæ¥æšããäœãããŠããŸãã ãããã¯æ£åžžãªå°¿éã®äœçœ®ãå éãã«ããç©ççãªç·åŒµã®éã«ééãæ¹åããhammock... ãã£ãšèŠã
å°¿äžç æ²»çè£ çœ®åžå ŽèŠæš¡ãšäºæž¬ - 2025 - 2032äžççãªå°¿çŽ åŠçè£ çœ®åžå ŽèŠæš¡ã¯ã2025幎ã«2åç±³ãã«ã§è©äŸ¡ããã2032幎ãŸã§ã®8.2%ã®ååç©å¹Žéæé·ç(CAGR)ã2025ãã2032幎ãŸã§ã«USD 3.8åã«éãããšäºæ³ãããŸãããããã£ãŒã«å°¿è·¯å äŸµå ¥æ²»çè£ çœ®ã¯ãäžéæã®å°¿è·¯ã管çãŸãã¯æ²»çããããã«èšèšãããåºç¯å²ã®å»çæè¡ãå å«ããŸãã ãããã¯ãå°¿éã®åãéã人工çãªå°¿ã®ã¹ãã£ã³ãã£ãŒãã«ããŒãã«ã黿°åºæ¿è£ 眮ããã³ããµãªãŒãåã¿ãŒã²ãã£ã³ã°ã®ç¹å®ã®åœ¢æ ã®å¿åãè¡åããŸãã¯æ··åãããæ¬èœãå«ãã æå°äŸµè¥²çã¹ãªã³ã°ã·ã¹ãã ã«ãããå°¿è·¯ã®å埩ããµããŒãããé«åºŠãªç¥çµå€èª¿è£ ... ãã£ãšèŠã
å»çãã€ãã¢ã¡ãŒã¿ãŒ åžå ŽèŠæš¡ãšäºæž¬ â 2025 â 2032ã°ããŒãã«å»çãã€ãã¢ã¡ãŒã¿ãŒ åžå ŽèŠæš¡ã¯ã2025幎ã«ç±³ãã«375äžãã«ã§è©äŸ¡ããã2032幎ãŸã§ã«615äžãã«ã®USDã«éãããšäºæ³ããã2025幎ãã2032幎ãŸã§ã®7.2%ã®ååç©å¹Žéæé·ç(CAGR)ãå±ç€ºããŠããŸãããããã£ãŒã«å»åŠã®dynamometerã¯èšåºããã³ã¹ããŒãã®è¬ã®èšå®ã®çè匷ããã°ãªããåããã³ãªãããªããŒã·ã§ã³ã®é²æ©ã枬å®ããã®ã«äœ¿çšããã蚺æå𿢰ã§ãã ãã³ããã«ãã®ããžã¿ã«ãæ²¹å§ãããã³ç¹å¿çãªå€åœ¢ãšããŠå©çšã§ããããããã¯ççåŠçæ³ã®è©äŸ¡ãå·å®³ã®è©äŸ¡ããã³åŠçœ®ã®èšç»ã®ããã®ç®çããŒã¿ãæäŸããŸ... ãã£ãšèŠã
Ecgã»ã³ãµãŒãããåžå Žã¯USD 212.7ã§è©äŸ¡ããããšæšå®ããã 2025幎ã®Mnã¯USD 2,691.3ã«éãããšäºæ³ããã 2032幎ã2025幎ãã2032幎ã«ãããŠ43.7%ã®è€å幎éæé·ç(CAGR)ãå±ç€ºã ã°ããŒãã«ECGã»ã³ãµãŒãããåžå Žã«é¢ããã¢ããªã¹ãã®ãã¥ãŒ:åžå Žã¯é£ç¶çãªãªã¢ãŒãã»ã¢ãã¿ãªã³ã°ãç¹ã«ãã¹ãCOVIDã®ããã®æé·ããèŠæ±ãããŸãå¯äžããŠããŸãã ç¡ç·ããã³æºåž¯çšECGã®ç£èŠã¯ç é¢ã®è² è·ãæžããéã¢ã¯ã»ã¹ã®å¢å ãå¯èœã«ããŸãã ããããã©ãŒã ã®èŠå ãšé©æ° ãŠã§ã¢ã©ãã« ã»ã³ãµãŒã¯ãæè¡ãå°ãªãäŸµå ¥æ§ãçºæ®ããŸãã 人æ°ã®é«ãäººæ° ãã¬ãã«ã¹ ç£èŠããã€ã¹... ãã£ãšèŠã
å®å®äººåžå ŽèŠæš¡ãšäºæž¬ - 2025 - 2032ã°ããŒãã«ã»ã€ã³ã¿ãŒã¹ããã¹ã»ã¹ããŒãµãŒã»ããŒã±ããèŠæš¡ã¯ã2025幎ã®USD 480,000,000ã§è©äŸ¡ããã2032幎ãŸã§ã®8.4%ã®ååç©å¹Žéæé·ç(CAGR)ã2025幎ãã2032幎ãŸã§æºãããšäºæ³ãããŸãããããã£ãŒã«éæ¥çãªã¹ããŒãµãŒã¯ãããŸã æ³šå ¥å¯èœãªå»çæ©åš è °ç¥çµã®èæ€ã®ççªãç©ããã«åé¢ããç¥çµã®å§çž®ãæžããããšã«ãã£ãŠç·©åããããã«èšèšãããŠããã äžè¬çã«ãçäœé©åæ§éå±ãããªããŒã§äœãããŠãããèé«ç®¡ç©ºéãç¶æããå¯åæ§ãæ¹åããåºç¯ãªèé«èåæè¡ãå¿ èŠãšããªãçã¿ãæå°éã«æããããã«ãèé«ããã»ã¹ã®éã«ã€ã³ãµãŒ... ãã£ãšèŠã
Hemoglobinopathyåžå Žã¯ç±³ãã«714.4ã§è©äŸ¡ããããšæšå®ããã 2025幎ã®Mnã¯USD 1,067.1ã«éãããšäºæ³ããã 2032幎ã«Mnã2025幎ãã2032幎ã«ãããŠ5.9%ã®ååç©å¹Žéæé·ç(CAGR)ãå±ç€ºãã°ããŒãã«ãã¢ã°ããããã·ãŒåžå Žã«é¢ããã¢ããªã¹ãã®æèŠ:æ¿åºã®ã€ãã·ã¢ããã®å¢å ã¯ãäºæž¬æéã«ããã£ãŠã°ããŒãã«ãã¢ã°ããããã·ãŒåžå ŽãçœåŒããããšãæåŸ ãããŸãã ããšãã°ã2020幎8æã«ã¯ãã€ã³ãèµ€ååäŒã®åœç«æ¬éšè¡æ¶²ãã³ã¯ã§ãã¿ã©ã·ãã¢ã¹ã¯ãªãŒãã³ã°ãšã«ãŠã³ã»ã©ãŒã»ã³ã¿ãŒãçºè¶³ããããããããè¯ãçæŽ»ãå°ãããã¢ã°ããããã·ãŒã«çœ¹æ£ããå°å ã®åºç£ãé²... ãã£ãšèŠã
ãŽã§ã€ã³ãã¡ã€ã³ããŒåžå ŽèŠæš¡ãšäºæž¬ - 2025 - 2032ã°ããŒãã«ã»ãŽã§ã€ã³ã»ãã¡ã€ã³ã㌠åžå ŽèŠæš¡ã¯2025幎ã®USD 260,000,000ã§è©äŸ¡ããã2032幎ãŸã§ã®8.2%ã®æ··åç©ã®å¹Žéæé·ç(CAGR)ãå±ç€ºããUSD 460,000,000ã«éãããšæåŸ ãããŸãããããã£ãŒã«éèãã¡ã€ã³ããŒè£ 眮ã¯ãéèå éèãéèå éèã«èšçœ®ããäºé²æ¥çš®ãããã³IVã¢ã¯ã»ã¹ãæ éçãšæ£è ã®äžå¿«æã軜æžããé䟵襲çèŠèŠåããŒã«ã§ãã 補åã®çš®é¡ã«ã¯ãèµ€å€ç·(NIR)ééã·ã¹ãã ããªã¢ã«ã¿ã€ã ã®ãããžã§ã¯ã·ã§ã³ãæ¡åŒµçŸå®ã®ãªãŒããŒã¬ã€ãã¿ãã¬ãããšçµ±åãããã·ã³ãã«ãªLEDããŒã¹ã®ãã©ã³ãžããŒã¿... ãã£ãšèŠã
城åç£èŠè£ 眮åžå Žã¯ç±³ãã« 7,827.1 ã§è©äŸ¡ããããšæšå®ãããŸã 2025幎ã®Mnã¯USD 14,868.8ã«éãããšäºæ³ãããŸã 2032幎ã2025幎ãã2032幎ã«ãããŠ9.6%ã®ååç©å¹Žéæé·ç(CAGR)ãå±ç€ºã ã°ããŒãã«ãã€ã¿ã«ãµã€ã³ç£èŠããã€ã¹åžå Žã«é¢ããã¢ããªã¹ãã®ãã¥ãŒ:äžçã®éèŠãªå°ã®ç£èŠè£ 眮ã®åžå Žæé·ã¯äœã質ã®ãããã¯ãã®å¯çšæ§ã«ãã£ãŠåŠšããããšãã§ããŸãã é«è¡å§ãé«è¡å§ãããã³è³åäžãªã©ã®å¿è¡ç®¡çŸæ£ã®æææ§ã¯ãäºæž¬æéã«ããã£ãŠäžççãªéèŠãªå åç£èŠè£ 眮åžå Žæé·ãä¿é²ããããšãæåŸ ãããŸãã äŸãã°ãäžçä¿å¥æ©é¢ã«ãããšã2021幎ãçŽ1.28å人ã®å¹Žéœ¢3079... ãã£ãšèŠã
è¶³ãšè¶³éŠã®ããã€ã¹åžå ŽèŠæš¡ãšäºæž¬ - 2025 - 20322025幎ãã2032幎ãŸã§ã®USD 4.6åç±³ãã«ã§äžçè¶³è»ããã³è¶³éŠè£ 眮åžå ŽèŠæš¡ãè©äŸ¡ããããšæšå®ãããUSD 7.9åç±³ãã«ã«2032åç±³ãã«ã«éãããšäºæ³ãããããããã£ãŒã«è¶³ããã³è¶³éŠè£ 眮ãããã¯ãã¯åºå®ã®çããã³ãããintramedullaryã®éãå€çãªåºå®åãè¶³éŠã®arthroplastyã®æ³šå ¥ãç·è¶³éŠã®åãæ¿ãã·ã¹ãã ãèåè£ çœ®(å å²ããéªšã®æ¥æšã®åãæ¿ã)ãè ±ã®ä¿®çæ³šå ¥å£ãorthobiologicsããã³æå°éã«äŸµç¥çãªå€åœ¢ã®å𿢰ãå«ãã§ããŸãã ãã¬ãŒã¹ããŠã©ãŒãã³ã°ããŒãããªãŒã¹ãºããžã§ã€ã³ãã¹ãã¢ãªã³ã°ã€... ãã£ãšèŠã
å 垯åžå ŽèŠæš¡ãšäºæž¬ â 2025 â 2032äžçå 垯åžå ŽèŠæš¡ã¯ã2025幎ïœ2032幎ãŸã§ã®USD 9.2åã§è©äŸ¡ãããUSD 14.6åç±³ãã«ã«éããèŠèŸŒã¿ã§ã2032幎ãŸã§ã«6.8%ã®ååç©ã®å¹Žéæé·ç(CAGR)ã6.8%ã§ãã£ãããããã£ãŒã«å 垯ã¯åºãã»ãããã«ããŒããŸã åµå·ã±ã¢ æ¥æ§ãæ ¢æ§ããã³å€ç§å·ãæž¡ãåŠçœ®ãä¿è·ããå§çž®ããåžåãããããŠä¿é²ããããã«èšèšãããŠãããããã¯ãã 補åã¿ã€ãã«ã¯ãã·ã³ãã«ãªç²çãã¬ãã·ã³ã°ãã¬ãŒãŒããã³ã³ã³ãã£ã®ã¥ã¬ãŒã·ã§ã³å 垯ããã€ããã³ãã€ãããã³ãã€ããã²ã«ãã¬ãã·ã³ã°ã湿ã£ãåµå·ç®¡çãæ³¡ããã³ã¢ã«ã®ã³é žå¡©ã®ãã¬ãã·ã³ã°ãã«ããŒãã«/ãã¥... ãã£ãšèŠã
è³ã®ãœãããã¯ã®ãªãã·ã¡ãŒã¿ãŒ åžå Žã¯2025幎ã®USD 227 Mnã§è©äŸ¡ãããUSD 386.5ã«éãããšäºæ³ããã 2032幎ã«Mnã2025幎ãã2032幎ã«ãããŠ7.9%ã®ååç©å¹Žéæé·ç(CAGR)ãå±ç€ºãGlobal Cerebral Somatic Oximetersã®ã¢ããªã¹ãã®ãã¥ãŒ åžå Ž:è³åäžãè¡åŸãªã©ã®ããŸããŸãªé害ã®èšºæã«ãããè³æ§çŸæ£ã®å¢å€§ ç¥çµèªç¥ç deficitsãªã©ã¯ãäºæž¬æéã«ããã£ãŠäžçè³ã®ãœããã£ãã¯ãªãã·ã¡ãŒã¿åžå Žãé§åããããšãæåŸ ãããŸãã ããšãã°ã2021幎12æã«ã¯ãåœç«ç ç©¶éçºæ³äººãã€ãªãã¯ãããžãŒæ å ±ã»ã³ã¿ãŒ(NCBI)ã«ãããšãäž»èŠ... ãã£ãšèŠã
ãšã¬ã¯ããã«ã«ãã£ã°ã©ã (ECG)ããã€ã¹åžå Žã¯ãUSD 6,440.4ã§è©äŸ¡ããããšæšå®ããã 2025幎ã®Mnã¯USD 8,532.3ã«éãããšäºæ³ããã 2032幎ã«Mnã2025幎ãã2032幎ã«ãããŠ4.1%ã®ååç©å¹Žéæé·ç(CAGR)ãå±ç€ºã äžççãªãšã¬ã¯ããã«ã«ãã£ãªã°ã©ã åžå Žã¯ãå¿è¡ç®¡çŸæ£(CVD)ã®è² æ ãäžæããäžçäžã®èã®äººå£ãå¢å ããŠããããã匷ãæé·ãçµéšããŠããŸãã ãŸããå¿èé害ã®èšºæããæè¡çã«é«åºŠãªECGã¢ãã¿ãŒã®æ¡çš/éèŠã®å¢å ã«å¯ŸããECGã«å¯ŸããéèŠã®å¢å ãæåŸ ãããŠããŸãã ããããè€éãªåéæ¹éãé«äŸ¡ãªèšåšã»ã¡ã³ããã³ã¹ãªã©ã®èŠå ã¯ãã°ããŒãã«é»... ãã£ãšèŠã
ã¯ããã管çããã€ã¹åžå ŽèŠæš¡ãšäºæž¬ â 2025 â 2032ã°ããŒãã«ã»ã¯ãããã»ãããžã¡ã³ãã»ããã€ã¹ã»ããŒã±ããèŠæš¡ã¯ã2025幎ã®USD 6.15åã§è©äŸ¡ããã2032幎ãŸã§ã®USD 10.92åã«éããèŠèŸŒã¿ã§ã2025幎ãã2032幎ãŸã§ã®8.2%ã®ååç©å¹Žéæé·ç(CAGR)ãå±ç€ºããŠããŸãããããã£ãŒã«ã¯ããã管çè£ çœ®ã¯æ©æ¢°ããæã£ãŠããŸã è¡æ åé€è¡ã·ã¹ãã ãåžåŒã®ã«ããŒãã«ãæ³šå ¥ã®ã«ããŒãã«ãvenaã®ã«ã ãã£ã«ã¿ãŒããã³DVTãPEããã³åèã®embolismsãæ±ãã®ã«äœ¿çšããããã¢ãã£ãã ãã³ãã ãããã®è£ çœ®ã¯æ¥éã«è¡æµãå埩ããè¡æ çã®ä¿¡é Œæ§ãæžãããåºè¡ãªã¹... ãã£ãšèŠã
èæ€æè¡è£ 眮åžå ŽèŠæš¡ãšäºæž¬ â 2025 â 20322025幎ã®USD 7.8åç±³ãã«ã§äžçèŠæš¡ã®Spineã®æè¡è£ 眮åžå ŽèŠæš¡ã¯æšå®ããã2032幎ãŸã§ã«USD 13.4åãã«ã«éãããšäºæ³ããã2025幎ãã2032幎ãŸã§ã®8.1%ã®ååç©å¹Žéæé·ç(CAGR)ãå±ç€ºããŠããŸãããããã£ãŒã«èæ±æè¡è£ 眮ã¯èæ±èåã®æ³šå ¥ã®æ³šå ¥ã®æ³šå ¥ã®æ³šå ¥ã®æ³šå ¥ã®æ³šå ¥è£ 眮ã人工çãªãã£ã¹ã¯ãããã£ãããéªšã®æ¥æšã®åãæ¿ããå«ã¿ãŸãã ãããã£ãã¯ã¢ã·ã¹ãå€ç§ã·ã¹ãã ãããã³éè¡ã¬ã€ããããåšæ¢°ã ãããã®è£œåã¯ãå®å®åãæžå§ããã£ã¹ã¯äº€æãããã³æå°éã®äŸµè¥²æ§èæ€æè¡ããµããŒãããŸãã ã€ãããŒã·ã§ã³ã¯ã3D... ãã£ãšèŠã
å»åŠã®ãã©ã¹ããã¯æŸåºã®åžå Žã®ãµã€ãºããã³äºæž¬â 2025 â 2032äžççãªå»çãã©ã¹ããã¯æŒåºåžå ŽèŠæš¡ã¯ã2025幎ã®USD 4.2åã§è©äŸ¡ããã2032幎ãŸã§ã®6.2%ã®ååç©å¹Žéæé·ç(CAGR)ã瀺ãUSD 6.3åã«éãããšäºæ³ãããŸãããããã£ãŒã«å»åŠã®ãã©ã¹ããã¯æŸåºãããã¯ãã¯ç®¡ãã«ããŒãã«ãè€æ°ã®å è ã®ãããã£ãŒã«ããå«ãã§ããŸã è¬å€é é é«ç²ŸåºŠããã³çç©é©åæ§ã®ããã«èšèšãããŠãããã£ãã«ããã³ç±åçž®ææã ãããã®è£œåã¯ãIVã»ãããéæåè·¯ãè žäŸçµŠã·ã¹ãã ãããã³æå°äŸµè¥²æè¡åšå ·ã§åºã䜿çšãããŠããŸãã è£œé æ¥è ã¯å ãèš±å®¹ãæ®ºèã®äž¡ç«æ§ããã³éèŠãªå»åŠã®é©çšã®æ§èœ... ãã£ãšèŠã
ã¹ãã€ãã¡ãŒã¿ãŒåžå Žã¯ã2025幎ã«1,377.7çŸäžç±³ãã«ãšæšå®ããã2032幎ã«ã¯2,600.5çŸäžç±³ãã«ã«éãããšäºæž¬ããã2025幎ãã2032幎ãŸã§ã®è€å幎éæé·çïŒCAGRïŒã¯9.5ïŒ ã瀺ããŠããŸãã ã¹ãã€ãã¡ãŒã¿ã®äžçåžå Žã«å¯Ÿããã¢ããªã¹ãã®èŠè§£äžçã®ã¹ãã€ãã¡ãŒã¿ãŒåžå Žã¯ãåŒåžåšçŸæ£ã®æç çã®å¢å ãé«éœ¢å人å£ã®å¢å ãæè¡ã®é²æ©ãåŒåžåšã®å¥åº·ã«å¯Ÿããæèã®é«ãŸããªã©ã®èŠå ã«ãã£ãŠçœåŒããããã€ãããã¯ãªåžå Žã§ããèºæ©èœã枬å®ããã¹ãã€ãã¡ãŒã¿ãŒã¯ãåæ¯ãæ ¢æ§é塿§èºçŸæ£ïŒCOPDïŒã®ãããªçŸæ£ã®èšºæã管çã«éèŠããããŸããããŒã¿ãã«æ©åšãé éå»ççµ±åãªã©ã®æè¡é©æ°ã¯ã補åã®ã¢ã¯... ãã£ãšèŠã